Headache Care Center
Family Medicine
Dr. Roger K. Cady, MD
|
|
Give Review
Doctor Roger K. Cady, MD works in the field of Family Medicine. He went to medical school at Mayo Medical School. Mayo Medical School is ranked 27 in research and 42 in primary care medicine He received awards:"Regional Top Doctor" and "Meaningful Use Stage 1 Certification". Doctor Roger K. Cady, MD is also a published doctor. He has 99 publication published. The most recent publication is: Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group. Dr. Roger K. Cady accepts Medicare payments and is registered with Medicare.gov.
Publications
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
- Acupuncture in the treatment of headache: a traditional explanation of an ancient art.
- A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine.
- A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET St...
- Red Flags and Comfort Signs for Ominous Secondary Headaches.
- Effect of noninvasive vagus nerve stimulation on acute migraine: An open-label pilot study.
- Chronic migraine in women.
- An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic M...
- Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination.
- Treatment of Chronic Migraine: A 3-Month Comparator Study of Naproxen Sodium vs SumaRT/Nap.
- SumaRT/Nap vs Naproxen Sodium in Treatment and Disease Modification of Migraine: A Pilot Study.
- OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
- Migraine and cognition.
- Sublingual Feverfew/Ginger (LipiGesic M) Reanalysis of Data.
- Evaluation of Sumatriptan-Naproxen in the Treatment of Acute Migraine: A Placebo-Controlled, Double-Blind, Cross-Over Study Assessing Cognitive Function.
- Advances in Drug Development for Acute Migraine.
- Two Center, Randomized Pilot Study of Migraine Prophylaxis Comparing Paradigms Using Pre-Emptive Frovatriptan or Daily Topiramate: Research and Clinical Implications.
- Rizatriptan for Treatment of Acute Migraine in Patients Taking Topiramate for Migraine Prophylaxis.
- Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and co...
- Naming Migraine and Those Who Have It.
- Satisfaction With and Confidence in Needle-Free Subcutaneous Sumatriptan in Patients Currently Treated with Triptans.
- A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
- Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
- Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan st...
- A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
- Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of use.
- Expanding access to triptans: assessment of clinical outcome.
- Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
- Sinus problems as a cause of headache refractoriness and migraine chronification.
- Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
- Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.
- The future of migraine: beyond just another pill.
- Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
- Predictors of adherence to triptans: factors of sustained vs lapsed users.
- Treating an acute attack of migraine.
- Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
- In-office discussions of migraine: results from the American Migraine Communication Study.
- Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
- Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
- The impact of topiramate on health-related quality of life indicators in chronic migraine.
- The epidemiology and pathophysiology of migraine.
- Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
- The convergence hypothesis.
- Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 10...
- Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.
- An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headache.
- Pathophysiology of migraine: implications to patient care.
- Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment.
- Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
- Optimizing the diagnosis and treatment of migraine.
- Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment.
- Understanding the patient with migraine: the evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headache.
- Simple and efficient recognition of migraine with 3-question headache screen.
- Sinus headache: a clinical conundrum.
- Pharmacologic management of migraine.
- Costs and outcomes of early versus delayed migraine treatment with sumatriptan.
- Sinus headache or migraine? Considerations in making a differential diagnosis.
- OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine.
- Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
- Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
- Healthcare provider-patient communication and migraine assessment: results of the American Migraine Communication Study, phase II.
- GERD prevalence in migraine patients and the implication for acute migraine treatment.
- Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
- Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase.
- Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsa...
- Diagnostic lessons from the spectrum study.
- Establishing principles for migraine management in primary care.
- The responsiveness of headache impact scales scored using ''classical'' and ''modern'' psychometric methods: a re-analysis of three clinical trials.
- Inhibition of diacylglycerol:CDPcholine cholinephosphotransferase activity by dimethylaminoethyl p-chlorophenoxyacetate.
- Treatment of acute migraine with subcutaneous sumatriptan.
- Electronic anesthesia. Electrotherapy in medicine.
- Oral sumatriptan in the treatment of recurrent headache.
- Recent advances in migraine management.
- Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.
- Improvements in health-related quality of life with sumatriptan treatment for migraine.
- Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX STATdose System.
- Standards of care for treating headache in primary care practice. National Headache Foundation.
- Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.
- Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group.
- Focus on primary care female population with migraine.
- Diagnosis and treatment of migraine.
- Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
- Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials.
- Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study.
- Treatment strategies for migraine headache.
- Economic implications of early treatment of migraine with sumatriptan tablets.
- Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
- Primary headaches: a convergence hypothesis.
- Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study.
- Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine.
- 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.
- A pilot study to measure cognitive efficiency during migraine.
- Analgesic rebound headache in clinical practice: data from a physician survey.
- A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT).
- A six-item short-form survey for measuring headache impact: the HIT-6.
- Inpatient treatment of headache: an evidence-based assessment.
- Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
- Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe.
Schools
Mayo Medical School
St Francis Hospital
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna
- American Republic
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Preferred Plus POS
- Blue Preferred Select
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- Humana
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Providence Health Plans
- Thrivent Financial
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
Education
-
Mayo Medical School
Drug Facts
| NPI NUMBER | 1558330878 | |
| NPPES Provider LastName | CADY | |
| NPPES Provider FirstName | ROGER | |
| NPPES Provider ZIPCode | 658076988 | |
| NPPES Provider State | MO | |
| Specialty Description | Family Practice | |
| Total Claim Count | 905.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 74.0 | |
| Percent Opioid Claims | 8.18 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558330878 |
| Last Name Of The Provider | CADY |
| First Name Of The Provider | ROGER |
| View All |
Similar Doctors
|
|
Dr. Rachel I. Toth, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kyle P. Smith, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia L. Flax, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark R. Ward, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jon F. Petersen, MD |
|
|
Dr. Filip J. Garrett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary A. Wardell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shelby R. Hahn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny M. Griffin, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott A. Dooley, MD |
|
|
Dr. Rachael J. Winston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip N. Wittmer, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Detten, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven D. Foote, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Allen K. Lea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald R. Butts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David I. Nawoor, MD |
|
|
Dr. Naomi C. Purdy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Baurichter, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. M S. Pennington, MD
This Doctor is OpenDoctor Recommended.
|